GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Total Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Liabilities | ₹3,967 Cr | ₹3,410 Cr | ₹3,193 Cr | ₹4,520 Cr | ₹3,012 Cr |
What is the latest Total Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
Year | Total Liabilities |
---|---|
Mar2025 | ₹3,967 Cr |
Mar2024 | ₹3,410 Cr |
Mar2023 | ₹3,193 Cr |
Mar2022 | ₹4,520 Cr |
Mar2021 | ₹3,012 Cr |
How is Total Liabilities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹3,967 Cr | 16.33 | |
Mar2024 | ₹3,410 Cr | 6.80 | |
Mar2023 | ₹3,193 Cr | -29.36 | |
Mar2022 | ₹4,520 Cr | 50.09 | |
Mar2021 | ₹3,012 Cr | - |
Compare Total Liabilities of peers of GLAXOSMITHKLINE PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAXOSMITHKLINE PHARMACEUTICALS | ₹52,807.1 Cr | -1.3% | -1.6% | 21.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,872.0 Cr | 0.7% | 2.8% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,609.0 Cr | -0.8% | 3.7% | 48.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,277.0 Cr | 3.4% | 11.2% | 17.9% | Stock Analytics | |
CIPLA | ₹119,184.0 Cr | -0.2% | -0.1% | -1.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,116.0 Cr | 0.6% | -5.2% | -4.9% | Stock Analytics |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAXOSMITHKLINE PHARMACEUTICALS | -1.3% |
-1.6% |
21.4% |
SENSEX | -0.1% |
1% |
1.8% |
You may also like the below Video Courses